{"cik":1176309,"taxonomy":"us-gaap","tag":"ContractWithCustomerLiabilityCurrent","label":"Contract with Customer, Liability, Current","description":"Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.","entityName":"ORAMED PHARMACEUTICALS INC.","units":{"USD":[{"end":"2018-08-31","val":2449000,"accn":"0001213900-19-000691","fy":2019,"fp":"Q1","form":"10-Q","filed":"2019-01-14"},{"end":"2018-08-31","val":2449000,"accn":"0001213900-19-006121","fy":2019,"fp":"Q2","form":"10-Q","filed":"2019-04-10"},{"end":"2018-08-31","val":2449000,"accn":"0001213900-19-012456","fy":2019,"fp":"Q3","form":"10-Q","filed":"2019-07-10","frame":"CY2018Q3I"},{"end":"2018-11-30","val":1131000,"accn":"0001213900-19-000691","fy":2019,"fp":"Q1","form":"10-Q","filed":"2019-01-14","frame":"CY2018Q4I"},{"end":"2019-02-28","val":2703000,"accn":"0001213900-19-006121","fy":2019,"fp":"Q2","form":"10-Q","filed":"2019-04-10","frame":"CY2019Q1I"},{"end":"2019-05-31","val":2703000,"accn":"0001213900-19-012456","fy":2019,"fp":"Q3","form":"10-Q","filed":"2019-07-10","frame":"CY2019Q2I"},{"end":"2025-12-31","val":1353000,"accn":"0001213900-26-059112","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-19"},{"end":"2025-12-31","val":1353000,"accn":"0001213900-26-087361","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-10","frame":"CY2025Q4I"},{"end":"2026-03-31","val":1471000,"accn":"0001213900-26-059112","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-19","frame":"CY2026Q1I"},{"end":"2026-06-30","val":1710000,"accn":"0001213900-26-087361","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-10","frame":"CY2026Q2I"}]}}